transfusion medicine. point 4 from the recent drafting of the Patient Blood Management Guidelines Module 6 - paediatric and neonatal. Further consideration to formal criteria and dose will be given to this condition when chapter 7 is re-developed in the next phase of the SWG work program. Review Criteria Dose Refer to the current product Refer to the current product information sheet for No change. information sheet for further further information. information. The aim should be to use the lowest dose possible The aim should be to use the that achieves the appropriate clinical outcome for lowest dose possible that achieves each patient.
transfusion medicine. point 4 from the recent drafting of the Patient Blood Management Guidelines Module 6 - paediatric and neonatal. Further consideration to formal criteria and dose will be given to this condition when chapter 7 is re-developed in the next phase of the SWG work program. Review Criteria Dose Refer to the current product information sheet for further information. The aim should be to use the lowest dose possible that achieves Refer to the current product information sheet for further information. The aim should be to use the lowest dose possible that achieves the appropriate clinical outcome for each patient. No change.
Haemolytic%20disease%20of%20the%20fetus%20and%20newborn%20%28HDFN%29_0.DOCX